Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso, Loris Riccardo; Petito, Valentina; Graziani, Cristina; Schiavoni, Elisa; Paroni Sterbini, Francesco; Poscia, Andrea; Gaetani, Eleonora; Franceschi, Francesco; Cammarota, Giovanni; Sanguinetti, Maurizio; Masucci, Luca; Scaldaferri, Franco; Gasbarrini, Antonio.
; 36(1): 56-65, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28683448
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Intestinal alkaline phosphatase: a summary of its role in clinical disease.
Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.
Microbial metabolites in health and disease: Navigating the unknown in search of function.
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity.
Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel.
Assessment of Environmental Enteric Dysfunction in the SHINE Trial: Methods and Challenges.
C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.